medical research lab in qatar

Sidra Medicine is a unique academic medical and research center based in Doha, Qatar. Our ambition is to carry out research that provides accurate and timely diagnoses for women and children with complex conditions, and to pioneer new approaches to disease management and treatments.

The Core Facilities at Sidra Research house innovative, state-of-the art platforms to support our mission and vision, from cutting-edge advanced diagnostics (applied genomics, proteomics, flow cytometry, microscopy, etc.) to advanced therapies manufacturing (Cell and Gene Therapy Facility). In addition, Sidra Research has an actively growing Clinical Trials Office that leads clinical studies to transform patient care through research.

Over the years, we have established strategic partnerships with service providers to bring these platforms to the wider local and regional community. Our experienced staff also offer regular training, education and capacity building initiatives for students and the scientific community in Qatar and beyond.

Core Facilities

Integrated Genomic Services

Genomics, Bioinformatics and Animal Model services

Research Operations And Services

"One-stop-shop” approach and solution-oriented admin service to researchers and clinicians

Digital Health

Digital ecosystem to support all computational aspects

Dedicated Research Labs

Human Whole Genomes sequences

Research Labs/Cores

Clinical Researchers

ISO-certified GMP Facility

• (+974) 44142421
• [email protected]

BLOOD BANKS

CHILDREN HEALTH

WOMEN'S HEALTH

• Medical Diagnostics Solutions
• Turn Key Projects
• Life Sciences
• Analytical Sciences Solutions
• Molecular Diagnostic Solutions

Equipments, Reagents & Consumables

Medical and Instruments Scientific Corporation is engaged in supply of Medical equipment, Hospital consumables and pharmaceutical products.

By our dedicated service and pragmatic business view, we have acquired a wide range of business and reliable goodwill from our customers within a short period of company’s inception. We still spend considerable time to explore new business opportunities to expand our business presence.

Many factors have contributed to our success, mainly dedicated service, prompt execution, total commitment etc. We always give priority to these important factors which help us promote our business and bring more confidence in our business campaign

• Our Mission
• Core Values
• Our Key to Sucess
• INTRODUCTIION -->
• CORE VALUES
• OUR KEY TO SUCESS

Welcome to M.I.S.C

Medical and instruments scientific corporation (MISC) is one of the leading In Vitro Diagnostics Company dedicated to provide the world's best solution for Clinics, Hospitals, Laboratories, Blood Banks and Research Institutes in Qatar. Having exclusive alliances with world leading principals in, In Vitro Diagnostics, Biologicals, Life Sciences, Transfusion Medicine, and other allied segments.

More than valuing our exceptional quality products, we value the satisfaction of our clients and we strive towards achieving it, knowing the customer needs, to meet and exceed the service requirements. Our trained scientific application and service engineers strive to provide services round the clock on 24/7 basis.

The company has earn a good reputation among its customers in the respective fields of business. The Company’s business strategy has brought a tremendous worldwide business relation with famous multinational organizations located in Europe and United States.

Medical and Instruments Scientific Corporation is situated in Doha, the Capital of Qatar.

Our services

Dedicated to provide the world's best solution for.

• Laboratories
• Blood Banks
• Research Institutes

Our Prinicipals

Our portfolio.

Copyright© 2019 Medical and instruments scientific corporation (MISC). All Rights Reserved. | Powered by orangeqatar

Qatar Biomedical Research Institute QBRI

Careers Opportunities

Work with us.

As we build Qatar Biomedical Research Institute’s (QBRI) infrastructure, we demand excellence at all levels - in the people we employ, the facilities we use and in our partnerships with the best biomedical research institutions. We invite outstanding candidates to join our team of world-class researchers and develop personalized solutions for chronic and severe diseases. 

Intern with Us

QBRI is committed to the training and development of the next generation of scientists and highly skilled workforce by providing mentoring, advanced scientific and research training opportunities and career guidance to young scientists in the fields of basic, applied, translational and clinical research.

QBRI offers internship opportunities for exceptional undergraduate and graduate students in specific disease areas of diabetes, translational cancer and immunity and neurological disorders research. As an intern, it is a great opportunity to meet new people, explore exciting areas of scientific research and learn firsthand about biomedical research protocols and techniques. Every year QBRI conducts the Summer Research Program (SRP), which is an intensive research training for undergraduate students. To learn more about SRP please click here .

QBRI is a proud partner of Qatar Research Leadership Program (QRLP), a capacity building program offering unique opportunities for young scientists in Qatar to pursue careers in health and biomedical research. 

• QBRI at a glance
• Scientific Advisory Committee
• Partnerships
• Summer Research Program
• Diabetes Research Center
• Translational Oncology Research Center
• Neurological Disorders Research Center
• Core Facilities
• Publications

Welcome to medical laboratories .net

Medical Labs

All your medical tests at one place.

About Us: Since Dr Nawal Abdulkader has founded Medical Labs   in 1996, the labs have built an excellent and strong reputation in the field. After establishing our center of excellence in Doha, in 1996, the organization started to expand fulfill an unsatisfied market need for high quality medical labs. That makes us one of the fastest growing medical labs chain in Qatar and the region.

As the one of the first medical labs in Qatar, our lab results are recognized and meet the strictest international quality standards. We have an extensive menu of around 2000 tests covering the fields of Clinical Chemistry, Hematology, Immunology, Immunoassay, Parasitology, Microbiology, Molecular Biology, Pathology, and Genetics.

Our competitive advantages exist in our accurate test results based on using state of the art technology, medical expertise, and strict control on quality of samples. Also, what sets us apart from competition is our dedication to inform and educate our patients regarding their test results. Our team of professionals works closely and enthusiastically together to accomplish our main aim, which is exceeding our customers’ expectations and helping them lead a healthier life.

The staff within  Medical Laboratories-Qatar  demonstrates the following values as they conduct their day to day activities:

Respect Caring Innovation Accountability Clinical Excellence Expert Diagnosis Continuous Quality Improvement Dedication to our Staff

Our Mission

Medical Laboratories-Qatar provides innovative, timely and high quality medical laboratory services providing comprehensive, high quality laboratory testing and patient-focused expert consultation contributing to excellent patient care. This mission is supported by new test development, exceptional customer service and continuous quality improvement.

Our Vision We will provide the highest quality laboratory services, testing and expert pathology diagnosis to our clients and patients.

Clinic Timings  In Morning: 8am to 1pm, In Evening: 4pm to 9pm, Thursday Holiday

We have an extensive menu of around 2000 tests covering in the following areas:

Clinical Chemistry

Clinical chemistry (also known as chemical pathology, clinical biochemistry or medical biochemistry) is the area of chemistry that is generally concerned with analysis of bodily fluids for diagnostic and therapeutic purposes.

Haematology, is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. It involves treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation.

Immunology is the study of the immune system. The immune system is the parts of the body which work against infection and parasitism by other living things. Immunology deals with the working of the immune system in health and diseases, and with malfunctions of the immune system.

Immunoassay

An immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody (usually) or an antigen (sometimes).

Parasitology

Parasitology is the study of parasites, their hosts, and the relationship between them. As a biological discipline, the scope of parasitology is not determined by the organism or environment in question, but by their way of life.

Microbiology

Microbiology is a science in the composition of biology, which is occupied by the study of microorganisms. Into the field of the interests of microbiology enter their systematics, morphology, physiology, biochemistry, evolution, role in the ecosystems and also the possibility of practical use. Bacteriology is a division of microbiology.

Molecular Biology

Molecular biology is a branch of biochemistry which concerns the molecular basis of biological activity between biomolecules in the various systems of a cell, including the interactions between DNA, RNA, and proteins and their biosynthesis, as well as the regulation of these interactions.

Pathology is a significant component of the causal study of pathogens and a major field in modern medicine and diagnosis. Hence, ‘the study of paths’, by which disease comes.

Genetics is the study of genes, genetic variation, and heredity in living organisms. It is generally considered a field of biology, but intersects frequently with many other life sciences and is strongly linked with the study of information systems.

Clinic Insurance Companies

Sample text. ABOUT AXA INSURANCE COMPANY SMALL DESCRIPTION

SSample text. ABOUT ALLIANZ INSURANCE COMPANY SMALL DESCRIPTION

Sample text. ABOUT DAMAN INSURANCE COMPANY SMALL DESCRIPTION

Sample text. ABOUT QLM INSURANCE COMPANY SMALL DESCRIPTION

Meet The Team

Minicap Sebia flex piercing - HBA1C and HB Electrophoresis

MINDRAY BIOChemistry

CASA- Comptec Assisted Sperm Analysis

BIOSAFETY Cabinet for MicroBiology

Our Liboratory

Read what our customers say

I have been here a few times and the staff is always pleasant. The speed of the results are good. 

حلو تعاملهم وفحص الدم م يطول👍🏽 (Translated by Google) Their sweet treatment and the blood test is not long

ashwaq alhamdani

Blood group certificate done quickly with no appointment for standard rate of 15 QR

James Gannon

Friendly staff, results by email as soon as they are out.

Our Location

Phone +097 44356492, 44353950 Location: Alghadeeriyat street, Bihind Landmark Mall, Duhail mail: [email protected]

• Our Customer

Call Us: (+974) 44931853

Visit Us: Office#3, Doha, State Of Qatar.

Full-Solution Distributor for Medical and Life Science

Atlantic Medical is a leading distributor in the Qatar Medical Device and Life Science Industries, and to provide world-class representation.

About Atlantic Medical & Lab Supplies

We aspire to be leading provider of quality lab products to medical and life Science customers.

Vision Statement

Atlantic Medical is a leading distributor in the Qatar Medical Device and Life Science Industries, and to provide world-class representation and distribution services to global medical and life science manufacturers.

We are a Medical Diagnostic company specializing in the supply of laboratory-based diagnostic products and is active in many fields from Serology to Microbiology, Virology, and Molecular based testing. Our source of differentiation will be in our distribution and marketing strategies. We will leverage our corporate account relationships and create marketing programs to drive demand for our products solutions for our customers and Healthcare Market.

It is about connecting the right people, products, and technologies. Globally. Locally.  For those needing more. Who we work with tells a stronger story than anything else we could say. We’re proud to call these companies “partners”.

1) The product technology is available to all players in this market. We will differentiate ourselves by adding value through our distribution strategy and channels, and our comprehensive product lines and programs that make working with us incredibly easy. 2) We are uniquely positioned to gain market share in this segment due to our corporate account relationships, our ability to build a regional (ultimately national) field clinical sales team quickly, and our ability to create compelling marketing programs 3) Focused on life science and medical devices and have a deep understanding of our market.

Our Customers In Qatar

• Governmental ministries and agencies including Ministries of Health,
• Environmental, Municipality, and Agriculture.
• Qatar Red Crescents.
• Hamad Hospital, Sidra and Private hospitals.
• Medical institutions, clinics, and physicians.
• Industries including biotechnology, food, and petrochemical industries.

Uniquely Broad Market Reach

Hospitals & Central diagnostic and contract labs

• Automated and manual platforms for clinical diagnostics.
• Laboratory automated workstations.

MARKET POTENTIAL

As QATAR Government is investing in healthcare and research, we would like to be part of the growth strategies. Qatar Government is investing 3 % of the GDP in the Healthcare sectors. Many Institutions such as Hamad Hospital, Cuban Hospital, and Al Wakra Hospital, and Private hospitals and Clinics in Qatar. Sidra, Qatar University, and Hamad Bin Khalifa University are focusing more on diabetes and cancer research, which offer is huge potential for laboratory products.

Products And Services

Trusted principals.

Our source of differentiation will be in our distribution and marketing strategies. We will leverage our corporate account relationships and create marketing programs to drive demand for our products solutions for our customers and Healthcare Market.

• Fisher Scientific, UK – Lab Equipment & Consumables
• Thomas Scientific
• Cole-Parmer, USA – Lab Equipment & Consumables

COMPETITIVE ADVANTAGE

1) The product technology is available to all players in this market. We will differentiate ourselves by adding value through our distribution strategy and channels, and our comprehensive product lines and programs that make working with us incredibly easy.

2) We are uniquely positioned to gain market share in this segment due to our corporate account relationships, our ability to build a regional (ultimately national) field clinical sales team quickly, and our ability to create compelling marketing programs. 

We’re proud to call these companies “partners”. We are a Medical Diagnostic company specializing in the supply of laboratory-based diagnostic products and is active in many fields from Serology to Microbiology, Virology, and Molecular based testing.

Our Principals

Medical institutions, clinics, physicians

Government ministries and agencies.

General imaging i.e. MRI, CT, Ultrasound.

Women's healthcare.

Dialysis machines and consumables.

 Chemical analysis instruments e.g. GC, HPLC, GC-MS, LC-MS, ICP-MS, and consumables.

 Kits for food & feed hygiene and analysis.

Clinical Diagnostics 

Microbiology Products

Virology Products

Molecular Based Testing

Get Best Services

Get a quote for testing

(+974) 44931853

[email protected]

Copyright © 2024 Atlantic Medical & Lab Supplies | Powered By Creative Web Design

Quick Contact

We are a dynamic company and growth-oriented, our sales growth rates will be much higher than the industry, especially given that we are competing in a small niche with the fragmented competition. We are constantly improving and evolving as markets, products and technologies evolve. 

Quick Links

Concord Business Center,

Al Meena Street, 4th Floor, Office#3, Doha, State Of Qatar.

Pin: 32367.

Fast Service

Online Help

Quality Products

With top service standards

Call us for  lab products to medical & life Science

Bringing products to markets

Best in the field of Medical Laboratories

Your trusted partner in the field of medical health care, operates with fully automated modern.

Your trusted partner for all your medical needs!

Equipment under the direct supervision of well qualified and experienced medical professionals.

An advanced medical laboratory for all your needs.

The quality of our service and the professionalism of our staff are the reason for our success.

Qualified Technician

Our team came from different medical specialties and diversified field of studies around the globe that makes the foundation on AL-Noor; Strong, competent and effective.

Customer Care

We are always aims to give 100% patient and physician satisfaction. We also assures that all the feedbacks, suggestions and complaints are being taken care of , put to record, replied back and used to improve the services.

Cost Effective

Alnoor Lab performs morethan 300 test parameters in-house, also provides health check-up profiles and customised packages that will cater the personal needs at affodable tariff.

Opening Hours

• Saturday - Thursday 7:00 AM - 10:00 PM
• Friday Closed
• Public Holiday Closed

Visitors Hours

Why people choose al noor medical laboratory .

Al Noor Medical Laboratory is well equiped diagnosis medical laboratory in Qatar. We provide quality and reliable laboratory services across Qatar at its best price.

We are focused on providing advanced medical techniques and tests in our laboratory.

Our mission is to stay up to date with the latest lab technologies, give quality tests and reports, and attain excellent customer service.

Our Department

• Biochemistry & Endocrinology
• Immunology & Allergy
• Microbiology Department
• Hematology & coagulation
• Serology Department
• Histo / cytopathology

Welcome to our Biochemistry & Endocrinology

The Department of Biochemistry and Endocrinology at Al-Noor Laboratories performs various qualitative and quantitative examination of biological fluids such as blood for specific chemical constituents or analytes. These tests are of value in screening and diagnosis of diseases and monitoring the progression of the disease.

Examples of tests offered in the department:

• Evaluation of general body condition
• Screening, diagnosis and monitoring of diseases
• Evaluation of bodily factors causing diseases
• Organ function assessment and monitoring
• Disease predisposition analysis

Welcome to our Immunology & Allergy

The Department of Immunology and Allergy provides cutting-edge technology for the most common allergic conditions such as food and drug allergy, atopic dermatitis, asthma, allergic rhinitis, hypersensitivity reactions and others.

The department continues to collaborate with many Pediatric specialists for better patient medical intervention. In most cases, allergic diseases are diagnosed through a combination of patient detailed history and results of test panels on allergy.

Welcome to our Microbiology

The Microbiology Department specializes in the diagnosis of infectious diseases covering areas in bacteriology, mycology, parasitology and virology. We are constantly monitoring and developing our methodologies in order to provide superior outcomes when it comes to detection, species identification, culture and sensitivity testing.

The testing procedure usually starts from the collection of appropriate specimens. These specimens may come from a variety of sources which will be sent to us for appropriate testing. We always believe that a good specimen will produce better chances for a definitive diagnosis. That is why we ensure that we employ carefully structured pre – analytical system for sample collection including specimen transport.

Welcome to our Hematology & coagulation

The Department of Hematology and Coagulation Studies delivers full service laboratory testing of blood, bone marrow and other body fluids and tissues. Our department covers all aspects of both routine and reference testing for various diseases such as anemia, leukemia, proliferative disorders, coagulation and other related disorders.

Most issues related to disorders of the blood usually arise from problems with cell count, cell morphology and cell function. Complications resulting from abnormalities in cell counts usually includes common disorders such as anemia and leukemia. Furthermore, defects in cell morphology and function attribute to a multitude of disorders which can be useful to provide a definitive diagnosis to the patient.

Welcome to our Serology

The Serologic tests are blood tests that look for antibodies in your blood, there are various tests which are used to diagnose various disease conditions. Our department perform all the laboratory tests using latest technology and advanced machines.

Welcome to our Histocytopathology

The Histocytopathology Department provides comprehensive cell and tissue diagnostic services to the clients of Al-Noor Medical Laboratories. The team is led by a certified Pathologist and composed of highly qualified and skilled histotechnologists which all aim to deliver the best laboratory services using cutting edge methodology and instrumentation in tissue processing.

The department deals with the processing of tissue samples for study under the microscope by qualified healthcare practitioners. These tissue samples are collected either during surgery or during a variety of tissue collection procedures and are subsequently processed to prepare slides that are of high quality.

TEST PACKAGES

Master health checkup basic.

• 30 Test Parameters
• Sample Collection @Home
• Fast & Easy reports
• Doctor Assistance
• Any time customer care

Master Health Checkup Premium

• 80 Test Parameters

Master Health Checkup Advanced

• 42 Test Parameters

Kidney Profile Basic

• 3 Test Parameters

Advanced Kidney Profile

• 9 Test Parameters

Basic Liver Profile

• 6 Test Parameters

Advanced Liver Profile

• 12 Test Parameters

Basic Thyroid Profile

Advanced thyroid profile.

• 5 Test Parameters

Male Fertility Test Package

Female fertility test package, allergy profile (20 allergen).

• 40 Test Parameters

Rheumatoid Arthritis Package

Rheumatoid arthritis package advanced.

• 15 Test Parameters

Heart Health Package

Tumor markers package - male.

• 8 Test Parameters

Tumor Markers Package - Female

BOOK A TEST

If you want to book a test with any department just fill up the form with valid data and we will contact you via phone/email for further proceedings.

Years of experience

Happy patients, number of staff, number of samples, patients say about us.

One of the best laboratory to make medical tests. Well maintained medical center in Qatar with good staff who are very professional.

Mr. Rejith Ramachandran

We recently visited here for my Father's checkup. Great facility was provided and gave quality report on time.

Ms. Annie Vincent

Al Noor laboratory is great,especially in terms of the quality of all staff and doctor.The results are accurate. Well advanced medical laboratory in Qatar.

Mr. Martha M

Frequently Asked Questions

How to book a test on al-noor's website, what are the test packages, i have no disease and look perfectly fine. why should i get myself a test package, get in touch.

Villa NJ-6, Al Muntaza Street, Near Al Tadamoun Signal, Doha - Qatar

44553737 / 44553838 / 55773020 Fax: 44553939

[email protected] Facebook: #alnoorlaboratories

Tests included in

• Arabiccc --> عربي English -->

• Vice President’s Message
• Vision & Mission
• Organizational structure
• International Advisory Board
• Local Industry Committee
• QU Health in News & Media
• Health Pluse
• College of Health Sciences
• College of Medicine
• College of Pharmacy
• College of Dental Medicine
• College of Nursing
• Clinical Affairs
• Research and Graduate Studies
• Academic Quality and Strategy
• Clinical Operations and Engagement
• Interprofessional Education
• Continuous Professional Development
• Programs Overview
• Phd in Health Science
• MSc in Biomedical Science
• MSc in Genetic Counselling
• MPh in Public Health
• MSc in Pharmacy
• Doctor of Pharmacy
• VP biography
• Vision and Mission
• Health Pulse
• Upcoming events
• Annual-Report
• Welcome message from AVP of Clinical Affairs
• Clinical Education
• Clinical Research
• QU Health Members
• Conferences
• Basic Techniques Laboratory Session
• Research Network Groups
• Student Research
• QU Health Core Facilities and Affiliated Centers
• Research seminar
• Academic-Planning
• Development of new Programs
• Curriculum Enhancement
• Learning outcome assessment
• Academic Program Review
• Institutional and Programmatic Accreditation
• QU Policies & QU Health guidelines
• Chair's Message
• IPE Learning Activities
• IPE Student Association
• IPEC Newsletter
• IPE Passport Program
• QU Health Strategy 2020-2025
• CPD in Media
• Spring 2024
• Spring 2023
• Spring 2022
• Scholarly Contribution
• Subscribe to Our Mailing List
• Objectives & Learning Outcomes
• Admission Requirements & Required Documents
• Degree Requirements
• How to Choose your Supervisor
• How to Choose Your Track
• Graduate Certificate and MSc in Health Professions Education

PhD in Health Sciences

The PhD in Health Sciences is governed by the “QU Health Graduate Studies Office” chaired by the Office of Graduate Studies at QU Health.

The PhD program in Health Sciences has two specialization:

• Biomedical and Pharmaceutical Research
• Clinical and Population Health Research

The PhD is to be awarded by QU Health, as a college, which was approved by Qatar University board of regents in April 2021. The program provides students with foundations in biomedical, pharmaceutical, clinical and population health. The PhD program aims to develop scientists who will contribute to the biomedical, pharmaceutical, clinical and population health disciplines through creative research and scholarship. The ultimate goal is to develop future generations of innovative health scientists who will solve pressing health problems and contribute to the Qatar health vision and well-being of the population. The program has an intense research focus and the duration of the curriculum is four years with a total of 60 credit hours. The program admits students on a full-time basis.

Dual PhD degree with RCSI

QU health has signed an agreement with RCSI for a dual PhD degree. Under this scheme, students will spend their first two years of study at Qatar University (and will take the required PhD courses) while the students will continue their third and fourth years of study at the Royal College of Surgeons in Ireland (RSCI). The first enrollment of students under this scheme will be for Fall 2023. Competitive graduate scholarships by QU-RCSI are available. To join, please apply to the PhD in health Sciences through  Online admission application  and for scholarship through  Graduate Assistantships (GA)

Click here for the Study Plan

The curriculum incorporates formal lectures, group projects, research presentations, journal clubs and writing review articles, to develop the students’ ability for critical thinking, intensive scientific writing, and problem-solving skills through research. All components of the PhD program are conducted in English. The length of the educational and training components has been benchmarked against well-established international institutions. The educational and research outcomes gained by the students throughout this program will be of a high international standard given the high-quality mentoring opportunities and state-of-the-art research facilities offered by QU Health. The educational content is tailored to address the local needs and the current healthcare environment in Qatar. The program has established links with several educational and medical institutions in the USA, UK, Canada and Australia to facilitate collaboration in the areas of teaching and research. Moreover, the PhD program is closely collaborating with prestigious national research, medical and educational institutions within the State of Qatar, such as Hamad Medical Corporation (HMC), Sidra Medicine, Weill-Cornell Medicine-Qatar (WCM-Q), interim Translational Research Institute (iTRI), the Neuroscience Institute, the Metabolic Institute, Qatar Biomedical Research Institute, Primary Health Care Corporation (PHCC) and the National Center for Cancer Care & Research (NCCCR). The PhD program has established several dual/ joint degree agreements with leading international Universities, including at this stage, University of Alberta (Canada), McGill University (Canada) and Royal College of Surgeons in Ireland (RCSI).

The current program has attracted significant recognition as the main research-based PhD in health sciences in Qatar. Many national, local residents and international students from diverse educational backgrounds have joined the program, including physicians, pharmacists, nurses, biologists and allied health professionals.

• Find a Doctor
• Patient Portal
• Medical Records
• Appointments
• Patient Feedback
• All Clinics & Services
• Clinical Support Services
• Women's Services
• Outpatient Clinics
• International Patients
• Children's Services
• Pharmacy Medication Request
• Before Your Visit
• Accessing care
• Health and Wellness Education
• During Your Visit
• Billing, Insurance and Financial Advice
• Child Car Seat Checking & Installation Station
• After Your Visit
• Patient's Bill of Rights
• Residencies and Fellowships
• Simulation Center
• Medical Education
• Continuing Professional Development
• Nationalization
• Clinical Library
• Graduate Medical Education
• Undergraduate Medical Education
• Advanced Research Core Services
• Precision Medicine For All Grant
• Principal Investigators
• Scientific Departments
• Advanced Cell Therapy Core
• Publications
• Precision Medicine Conferences
• Clinical Research

The Sidra Medicine Media Center is regularly updated. Here you can catch up on current events, read stories from patients who had their lives changed by Sidra Medicine, and contact us with any questions you may have about our medical services. 

• Patient Stories
• Filming Request Form
• Procurement

Genetic and Genomic Medicine

The Division of Genetic and Genomic Medicine at Sidra Medicine provides comprehensive genetic services including clinical evaluation and risk assessment; genetic counselling; diagnosis and the advanced management for a variety of genetic disorders in patients of all ages. The division also offers ongoing multidisciplinary care for patients with genetic conditions and helps them access resources and treatment programs personalized to their condition.

The division entails the diagnosis, treatment, prevention and research in genetic and genomic medicine with respect to precision medicine. It plays an important role in determining the risks of developing certain genetic diseases as well as screening and preventive treatment.

The service is a joint program provided in partnership with Hamad Medical Corporation (HMC). Patients under the age of 18 years, are seen at Sidra Medicine while those the rest at seen at HMC.

Conditions treated:

• Birth defects
• Growth problems
• Intellectual Disability and Developmental Delay
• Chromosomal disorders
• Microdeletion/duplication syndromes
• Craniofacial disorders  
• Neurocutaneous syndromes  
• Neuro-Muscular disorders
• Spinal Muscular Atrophy (SMA)
• Disorders of Amino Acids
• Disorders of Organic Acids
• Disorders of Hyperammonemia and Urea Cycle
• Disorders of Fatty Acid Oxidation
• Peroxisomal Disorders
• Lysosomal Storage Disorders
• Mitochondrial Disorders
• Neurometabolic Disorders
• Methionine and Homocysteine Disorders
• IEMs of vitamins and trace elements
• Inherited Connective Tissue disorders
• Inherited Bone Disorders/Skeletal Dysplasia
• Inherited skin (dermatological) disorders
• Inherited Hearing Loss
• Inherited Cardiovascular disorders/Cardiomyopathies
• Inherited eye Disorders
• Infertility and Disorders of Sex Development
• Inherited Ciliopathies
• Inherited Kidney and Renal Malformation
• Inherited liver disorders
• Inherited Cholesterol and Lipid Metabolism
• Positive personal/family history of any genetic condition/disorder with or without a known cytogenetic/molecular diagnosis
• Abnormal fetal ultrasound scans.
• Abnormal prenatal screening results.
• Abnormal prenatal diagnosis results.
• History of exposure to known teratogens, such as congenital infections (TORCH), medications, or radiation.
• Maternal diseases known to affect the fetus.
• Clinical Geneticists
• Biochemical Geneticists
• Prenatal Geneticists
• Genetic Counsellors
• Metabolic Dieticians
• Sub-specialty Genetic/Metabolic Nursing
• Genetic Databases
• Phlebotomy Services (Satellite lab)
• Research Services

This service works seamlessly with obstetricians, maternal-fetal medicine sub-specialists, neonatologists, pediatricians and internal medicine specialists to provide a family-based service.

• Diagnostic services and testing
• Genetic Counselling: We provide genetic counseling for all our patients, including
• Positive Carrier Cases identified through the Qatar National Premarital Genetic Screening Program
• And those undergoing Preimplantation Genetic Diagnosis (PGD) services
• Prenatal Genetic Diagnosis: Prenatal genetic testing and diagnosis offers information about whether a fetus has certain genetic disorders
• Newborn Screening Program: The genetic services team is responsible for the management of all positive cases identified by the Qatar National Expanded Metabolic Newborn Screening Program
• Inborn Errors of Metabolism (IEM): We also treat metabolic genetic conditions with diet modification and pharmacological therapy for Inborn Errors of Metabolism.
• Research: When and where appropriate, the service identifies research studies for which patients may qualify, to better understand their conditions or to provide additional therapeutic services. In collaboration with our research division, we also provide access to the latest testing techniques, when medically appropriate, such as whole-exome sequencing, to identify genetic variants

• Open access
• Published: 27 August 2024

Facilitators and barriers to interprofessional collaboration among health professionals in primary healthcare centers in Qatar: a qualitative exploration using the “Gears” model

• Alla El-Awaisi 1 ,
• Ola Hasan Yakti 2 ,
• Abier Mohamed Elboshra 1 ,
• Kawthar Hasan Jasim 1 ,
• Alzahraa Fathi AboAlward 1 ,
• Raghad Walid Shalfawi 3 ,
• Ahmed Awaisu 1 ,
• Daniel Rainkie 4 ,
• Noora Al Mutawa 3 , 5 &
• Stella Major 6  

BMC Primary Care volume  25 , Article number:  316 ( 2024 ) Cite this article

2 Altmetric

Metrics details

The number of patients seeking medical care is increasing, necessitating more access to primary healthcare services. As several of these patients usually present with complex medical conditions, the need for interprofessional collaboration (IPC) among health professionals in primary care is necessary. IPC is essential for facing the increasing and challenging healthcare demands. Therefore, the facilitators of and the barriers to IPC should be studied in the hope that the results will be used to promote such endeavors.

This study aimed to explore the perspectives of different health professionals regarding the facilitators of and the barriers to IPC in the primary healthcare settings in Qatar.

A qualitative study using focus groups was conducted within the Primary Health Care Corporation (PHCC) in Qatar. Several health professionals were invited to participate in the focus groups. The focus groups were uniprofessional for general practitioners (GPs), nurses, and dentists, while they were interprofessional for the other health professionals. Focus groups were audio-recorded and transcribed verbatim and validated by the research team. The data were analyzed by deductive thematic analysis using the “Gears” Conceptual Model as a coding framework.

Fourteen focus groups were conducted involving 58 participants (including 17 GPs, 12 nurses, 15 pharmacists, 3 dentists, and 11 allied health professionals) working in PHCC in Qatar. The findings revealed a spectrum of factors influencing IPC, categorized into four main domains: Macro, Meso, Micro, and individual levels, with each accompanied by relevant barriers and facilitators. Key challenges identified included a lack of communication skills, insufficient professional competencies, and power imbalances, among others. To address these challenges, recommendations were made to implement dedicated training sessions on IPC, reduce hierarchical barriers among different health professionals, and enhance the effectiveness of existing systems. Conversely, it was emphasized that projects and campaigns focused on IPC, alongside the development of enhanced communication skills and the presence of supportive leadership, as essential for facilitating effective IPC in PHCCs.

The interplay between the meso, macro, micro, and individual levels highlight the significance of a multifaceted approach to interventions, aiming to enhance the successes of IPC. While initiatives like interprofessional education training are underway, numerous challenges persist before achieving improved collaboration and more efficient integration of IPC in the PHCC setting.

Peer Review reports

Introduction

The World Health Organization (WHO) projects a global deficit of health professionals in comparison to the needs, expected to exceed 18 million by 2030, which will impede the provision of optimal healthcare services. In their “Global strategy on human resources for health: Workforce 2030”, they highlighted the need to equip health professionals with the skills needed to practice collaboratively in interprofessional teams [ 1 ]. One of the best solutions to face this strain on the healthcare system and to provide better management of the complex health challenges is to implement and promote the concept of interprofessional collaboration (IPC) as these demands often are beyond the expertise of any single profession [ 2 , 3 , 4 ]. According to the WHO, IPC occurs when “multiple healthcare workers from different professional backgrounds provide comprehensive services by working with patients, their families, caregivers, and communities to deliver the highest quality of care across settings” [ 2 ]. IPC recently has become one of the core demands of accreditors, funding institutions, policymakers, and practicing health professionals, recognizing its potential to improve the quality of care and address the increasing demand for healthcare services [ 5 , 6 , 7 , 8 ].

Research has consistently highlighted the positive impact of IPC on healthcare work processes, patient safety, and patient outcomes across various disease states such as diabetes, heart failure and asthma, which were treated in hospital, primary care, and community settings [ 9 , 10 , 11 ]. Research has concluded that a high degree of IPC has led to better subjective outcomes, including overall satisfaction, treatment success, and willingness to recommend the healthcare institution to others. Additionally, objective outcomes such as reduced mortality rate, readmissions, and hospital length of stay have been noted. Furthermore, collaboration has been associated with improved decision-making and increased innovation [ 12 , 13 ]. It has also been demonstrated that as the relationship and level of connectedness between physicians and other health professionals increase; hospitalization costs and readmission rates decrease [ 14 ].

Primary healthcare is the foundation of any country’s healthcare system. It is not only considered the primary point of contact with the healthcare system, but it also serves as the vehicle for ensuring continuity of care across settings. The increase in the number of people with multiple chronic diseases that are associated with considerable social, functional, and emotional impairment and an increase in the healthcare demand, leading to an increase in the needed services [ 15 , 16 , 17 , 18 ]. Consequently, policymakers on an international scale have persistently advocated for the greater integration of interprofessional team-based care in primary healthcare settings and the development of influencing factors that explicitly acknowledge the value of this collaborative approach [ 19 , 20 ]. Several studies in the literature have highlighted the positive outcomes associated with effective collaboration within primary healthcare settings [ 21 , 22 , 23 ]. This has led to an internationally movement towards team-based primary healthcare, to enhance the integration of services and to emphasize health promotion and chronic disease management [ 19 ]. Ineffective collaboration leads to an increased risk of preventable errors, lack of efficiency, and loss of motivation, resulting in suboptimal patient care based on nurses’ opinions [ 24 ].

While IPC efforts are usually initiated by policymakers, research have demonstrated that health professionals’ play a vital role in providing high-quality IPC. Therefore, it is of crucial importance to consider the perspectives of health professionals working in primary healthcare settings regarding IPC when designing and implementing IPC projects [ 25 ]. Numerous studies have examined IPC across various countries. For example, a systematic review was conducted to explore facilitators and barriers to IPC implementation in primary healthcare settings. This review included studies conducted in Great Britain, the United States, the Netherlands, Australia, Spain, Brazil, Canada, and New Zealand. The findings of this review indicated that allied health professionals generally hold positive perceptions of IPC within primary healthcare contexts [ 26 , 27 ]. However, limited research has been conducted to investigate healthcare IPC practice in Qatar, particularly in primary healthcare settings. Given the recent expansion of scope of practice in primary care in Qatar [ 28 ], it is essential to explore the current practices in primary healthcare in Qatar in terms of IPC facilitators and barriers, and determining the necessary steps to achieve optimal collaboration within the Qatari healthcare system.

This study is a continuation of a previous study that explored the perspective of 1415 health professionals in primary healthcare settings through a self-administered questionnaire [ 28 ]. Results of the study showed that health professionals generally have a positive attitude and readiness toward IPC. Interprofessional differences were noted regarding their readiness to be involved in IPC, where physicians had slightly more positive readiness towards understanding their professional identity compared to other health professionals. Health professionals with previous IPC or interprofessional education (IPE) experiences revealed greater, but non-significant positive attitudes toward IPC compared to those without previous experiences. Participants suggested that facilitators and barriers for IPC in primary healthcare settings are conceptual rather than physical. Facilitators included personal belief in IPC benefit, higher professional satisfaction, interprofessional respect, appreciation of other health professionals’ role, institutional support, and leadership. Barriers identified included lack of time, leadership, support, and limited resources.

In an effort to understand the health professionals’ perception of the facilitators and barriers for IPC in primary healthcare in Qatar, the current study will explore the factors affecting the IPC in primary healthcare in Qatar using the “Gears” conceptual model [ 7 ]. The Gears model offers a taxonomy of factors influencing IPC within Interprofessional Primary Care Teams (IPCTs). These factors are categorized into levels: policymakers (macro gear), organizational managers (meso gear), healthcare teams (micro gear), and health professionals (individual gear). Most of the factors identified by the “Gears model” are within the micro gear, or those affecting the individual. These involve formal processes such as quality audits and group problem-solving; social processes pertained to open communication and supportive colleagues; team attitudes such as feeling part of the team; and team structure such as team size and having a collaboration champion or facilitator. Macro gears/policy factors are those that change less frequently and are pertained to regulations regarding the general scope of practice, funding, etc. Meso gears/ organizational factors are those that change more often and affect more than one team in the organization, those are concerned with the information systems, organizational culture, etc. Individual factors include the individual health professional characteristics such as belief in IPC care and personal flexibility.

The aim of this study is to identify factors facilitating or impeding IPC in primary healthcare in Qatar by exploring the perspectives of health professionals working in primary healthcare qualitatively. These include GPs, nurses, pharmacists, dentists, and allied health professionals (lab technicians, physiotherapists, dieticians, and radiographers). Findings from this study will be used to find ways to enhance and promote collaborative practice in primary healthcare in Qatar.

Study design

In this qualitative study design, data were collected through semi-structured focus groups. A qualitative approach was used to explore comprehensively the lived experiences of health professional’s perspective as it allows for investigating a phenomenon from the people who have experienced it. It gives a deeper insight and answers to what, how, and why questions [ 12 ].

Study setting

The study was conducted among health professionals working in the Primary Health Care Corporation (PHCC) in Qatar. PHCC was established in 1978 to provide comprehensive primary healthcare services and became an independent body in 2012 with full administrative and financial autonomy. At the present time, the PHCC provides PHC through 27 PHC centers distributed across the country. Each center is staffed with health professionals who provide a broad range of services, focusing on health promotion and disease prevention. PHCC has adopted and implemented family medicine model of care and offers a wide range of services, including general medicine, dentistry, ophthalmology, optometry, ENT, dermatology, mental health, preventive and lifestyle services such as wellness, premarital care, cancer screening, gym and geriatric, physiotherapy and radiology services [ 29 ]. In February 2018, a local continuous professional development (CPD) program was initiated by PHCC Workforce Training Department (WFTD) for implementing learning activities across the 27 PHCC health centers using interprofessional and collaborative approaches.

Study participants and sampling

The study comprised 58 participants, including 17 general practitioners, 12 nurses, 3 dentists, 15 pharmacists, and 11 allied health professionals (e.g., laboratory technologists, radiologists, optometrists, and audiologists) working in PHCC in Qatar. A purposive sampling strategy was employed to select health professionals with experience or understanding of IPC, aiming to maximize participant recruitment and ensure representation of the study population’s views [ 16 ]. Sampling continued until thematic saturation was reached, indicating no further emergent ideas from discussions [ 17 ].

Participants’ recruitment

Emails were sent to the health professionals working at PHCC in Qatar inviting them to participate in the study focus groups that were planned to be conducted at Qatar University or PHCC headquarters. Recruitment of participants was facilitated through WFTD which took the responsibility of recruiting and arranging appropriate focus group schedule that can suit study participants. An invitation email was sent with consent form and participant information sheet to participants prior to the focus groups.

Data collection

The topic guide was developed through discussions with the research team, a review of previous literature, and based on phase 1 quantitative results [ 28 ] (please see supplementary file). A pilot interview was conducted with minor adjustments and included a few health professionals working in PHCC. Because no significant changes were made it was included in the final analysis. The focus group were uniprofessional (i.e. homogenous groups) for GPs, nurses and dentist and interprofessional (i.e. heterogeneous groups) for the remaining health professionals and varied in duration between 90 and 120 min. The discussions were audio-recorded and transcribed verbatim.

Data analysis

A deductive thematic analysis was conducted of data, which is an analytical method in which authors use existing themes, categories, or domains to categorize new data under such categories [ 30 ]. Participants’ ideas were categorized under four main domains adapted from the “Gears model” [ 7 ]. The gears model outlines the factors affecting IPC within IPCTs under four main factor domains: macro, meso, micro, and individual factors. AME, AA, KJ, RS reviewed and validated the transcripts. They then independently reviewed couple of transcripts to generate codes in discussion with the lead author (AE). Coding for the rest of the transcripts was validated by one faculty member from the research team. A final discussion took place with all authors to agree on themes and subthemes.

Reflexivity

During the data collection and analysis process, the research team engaged in reflexive practices to mitigate potential biases. The team consisted of various individuals with diverse backgrounds, including faculty members with pharmacy, nursing and medical backgrounds, three of whom were practicing health professionals, along with four pharmacy students and one alumna. The team offered a broad spectrum of perspectives and insights for data generation and analysis. These faculty members had an understanding of IPE and had previously conducted workshops on interprofessional collaboration for health professionals at PHCC. With a background in IPC, participants’ ideas were more easily understood, facilitating deeper engagement, and enabling the comprehension of their perspectives more readily, thus ensuring a comprehensive interpretation of the data. Throughout the research process, attention was paid to the potential influence of professional backgrounds, with reflexive practices employed to mitigate biases and ensure the integrity of the findings.

Data collection were mostly led by the principal investigator, with support from students adhering to a pre-defined topic guide to minimize personal biases. To further enhance trustworthiness of the study, students independently coded the data, which was validated by a faculty member of the research team. The team met several times to review and compare codes and themes, refining the analysis iteratively until consensus was reached. Each stage of the research process was overseen by the principal investigator, ensuring the rigor and robustness of the study.

Fourteen focus groups were conducted between September 2019 and February 2020, involving 58 health professionals working in primary healthcare centers in Qatar (17 general practitioners, 12 nurses 15 pharmacists, 3 dentists, and 11 allied health professionals). The baseline characteristics of the participants are summarized in Table  1 . Four domains, 10 themes, and 14 sub-themes were identified from the focus groups. The domains, themes, and sub-themes are summarized in Table  2 .

Gears domain 1: macro factors

Facilitators, theme 1: the influence of organizational policies on ipc.

Several factors were identified by health professionals pertaining to the policies that can affect IPC. These factors were mainly related to the rules and regulations set by the organization’s managers or government bodies, which typically influence the general scopes of practice, funding mechanisms, and remuneration of providers. Consensus was reached that these regulations play a significant role in fostering IPC among health professionals.

“Actually , we have very well prepared and organized policies. Policies related to teamwork , which align with best-practices and international guidelines. The policies at our PHCC facilitate collaboration… but how to use it? Is everybody aware of its use?” [Laboratory technologist 1].

No major barriers were identified under the macro factors.

Gear’s domain 2: meso factors

Theme 2.1: leveraging technology for enhanced communication.

Participants unanimously agreed that the current health information system, specifically CERNER, serve as a strong facilitator for enhancing communication among health professionals. It enables seamless sharing of patients’ details documented by other health professionals.

“I find the CERNER system software amazing , because you can get to see the history of the patients and previous appointments records. Everything is well documented” [Dentist 3].

Theme 2.2: communication hindered by limitations in healthcare information system utilization

Several participants noted that current system (CERNER) is not fully utilized for documenting and reporting of medical or medication errors which can serve as a barrier. As an example, one participant expressed reluctance to utilize the system and filing an OVA (incidental report) for fear of retaliation in case the reporter is identified.

“If I were to write OVA (incidental report) for him/her , he/she will get angry at me. So , there’s no use. Actually , the purpose is to report in order for others to learn from them , but there is no clear pathway that there will be no consequences for us reporters” [Nurse 2].

Furthermore, another HCP mentioned that the current information system might be a barrier, as not all health professionals have equal access to the system.

“The pharmacist is not allowed to enter a recommendation into the system; they have their own system” [GP 5].

Theme 2.3: barriers in organizational dynamics hindering IPC

Sub-theme 2.3.1: hierarchy hinders collaborative spirit.

One of the primary obstacles to collaboration within the institution is perceived to be the presence of a hierarchical structure. This perception is based not only in the observable existence of a grading system that categorizes health professionals according to their profession and seniority, but also in the benefits associated with higher hierarchical positions.

“The hierarchy is influenced by salary differences” [GP 4].

Participants in the study observed that this hierarchical system leads to disparities, which undermine their willingness to collaborate. As an example, pharmacists expressed feeling of being treated differently compared to GPs, who are routinely offered opportunities to attend international conferences. The lack of such opportunities for pharmacists and other health professionals further reinforces the perception of hierarchy within the institution.

“I have tried to attend a conference; I have a right to enhance my education. Why does this apply to the GP and not to the pharmacist?” [Pharmacist 8]. “He -the GP- thinks that the pharmacist as being of lower status , and he is the only one to have the authority to write and make decisions” [Pharmacist 9].

Sub-theme 2.3.2: blame culture instils apprehension among health professionals

Another significant factor that had a considerable impact on collaborative efforts was the existence of a culture of blame within the PHCC organization. This culture of blame surfaced frequently during discussions among health professionals and was found to hinder effective collaboration among team members. Some perceived the level of blame not to be equitable.

“What if I did a mistake? And what if the mistake was done by the GP? The blame wouldn’t be equal. We would receive more blame” [Nurse 3]. “I still believe that some of us should refrain from perpetuating a blame culture or name-calling. After all , all of us are human beings. We are prone to making errors” [GP 10]. “We need to promote a culture of no blame. When things go wrong or mistakes occur , we should view them as collective challenges rather than assigning fault to individuals and subjecting them to humiliation. This approach will significantly transform the overall attitude within the environment” [GP 2].

Sub-theme 2.3.3: Lack of feedback contributes to the perception that health professionals’ efforts are undervalued

Some health professionals have expressed concerns regarding the lack of feedback on their performance, interventions, and error reports, particularly within Datix, a patient safety software utilized for healthcare risk reporting. This absence of feedback is perceived as a significant impediment to IPC, as it fosters the perception that the efforts of health professionals are not adequately acknowledged or valued.

“The risk management team should gather data and determine the significance of incidents reported through Datix , which is serious or recurring. If a mistake is repeated , they will ask or make an investigation about this issue. However , aside from these instances , no action is taken. No feedback is provided” [Pharmacist 1].

Gears domain 3: micro factor

Theme 3.1: expanding the scope of practice of team members enhances collaboration.

Given that IPC heavily relies on teamwork, the topic of collaborative efforts and teamwork surfaced frequently during focus groups.

“ The most important thing in primary healthcare practice is the teamwork. We underscore its importance , as it permeates our daily operations” [GP 6].

Expanding the scope of practice of healthcare team members has the potential to foster enhanced collaboration between team members. For example, pharmacists who participated in the discussions expressed that the inclusion of a clinical pharmacist within PHCC would enhance collaboration. This is attributed to the direct involvement of the clinical pharmacist with the interprofessional team, which obviates the need for external prompting to initiate collaborative efforts.

Theme 3.2: effective communication channels foster collaboration

Effective collaboration among participants was found to significantly hinge on the establishment of robust communication channels. This encompasses both formal features and tools, ranging from cordial and conversational telephonic exchanges to more structured modes of communication, such as the sharing of electronic patient records. Several participants cited instances of proficient communication that had led to successful collaboration outcomes.

“Every colleague should be encouraged to express their concerns , whether in written form or verbally , as it facilitates communication” [Dentist 3]. “Many doctors respect our opinion and express gratitude , acknowledging that we draw their attention to certain points“ [Pharmacist 9].

The majority of participants highlighted the importance of communication tools provided by the institution, including telephones, the CERNER system, and email platforms. Participants expressed their appreciation for these communication channels, noting that they effectively save time and enable seamless collaboration, even when they are attending to patients in different locations.

“It’s not difficult because we have our colleagues , whom we can contact directly by phone” [Dentist 1].

Theme 3.3: formal team processes have a significant role in facilitating collaboration

Sub-theme 3.3.1: supportive leaders empower team members to collaborate.

Leaders who demonstrate appreciation and dedication play a crucial role in fostering positive experiences of IPC. Regular interprofessional meetings organized by these leaders ensure that the environment is conducive to collaboration, and support empowering health professionals to initiate and engage in collaborative endeavor.

“So , if we have any issues , we talk to our supervisor , who then reports it to the health center manager. She is really supportive” [Pharmacist 3].

Sub-theme 3.3.2: engagement in interprofessional initiatives enhances collaboration among team members

Participants emphasized that their involvement in workplace initiatives, such as projects, campaigns, seminars, and workshops, played a crucial role in promoting IPC. According to health professionals, these initiatives were beneficial as they provided them with diverse professional perspectives, opinions, and ideas, which in turn enhanced their chances of success in their collaborative efforts.

“In our health center , we initiated a project to improve the practice of antibiotic prescribing. We were collaborating with GPs to know from them how to write and put a protocol to lessen the misuse of antibiotic” [Pharmacist 2].

Participants also recognized that engaging in collaborative research activities involving multiple team members was an effective facilitator for enhancing patient safety.

“I conducted research on medication use reviews , actively engaging with general practitioners’ clinics. I would regularly visit these clinics to share information about the study. During these interactions , I explained my criteria , encouraging them to refer eligible patients to the pharmacy” [Pharmacist 6].

Furthermore, vaccination campaigns were considered essential by several pharmacists as they provided opportunities for collaboration with other disciplines including educational outreach events. Several pharmacists reported on their involvement in these campaigns and the subsequent positive impact on collaboration dynamics. Specifically, one pharmacist highlighted a reduction in the uptake of pneumococcal vaccine among eligible patients and assumed a proactive role by gathering information from various GPs regarding the decreased prescription of such vaccines.

“We did a project in collaboration with GPs , regarding vaccinating high risk patients with pneumococcal vaccine” [Pharmacist 4]. “During the immunization week , I held a seminar about immunization. I taught them -nurses- individually how to use each vaccine properly and why we are using it” [Pharmacist 2].

Moreover, participants found case-based discussions and interprofessional training sessions with other health professionals valuable for collaboration. These sessions allowed discussion of each profession’s role and facilitated idea exchange.

“ As part of our interprofessional education efforts , we conduct weekly lectures and brief discussions for an hour… sometimes , new nurses and physiotherapists attend these lectures…… We discuss how we can help promote the collaboration between all of us for better care for the patients” [GP 9].

Sub-theme 3.3.3: optimizing accessible healthcare environments

Experiences related to the impact of the environment on collaboration were generally positively perceived. For instance, the close proximity of a nurse diabetic educator to the pharmacy facilitated direct communication between pharmacists and educators, enabling them to address any concerns more efficiently. Moreover, having practitioners co-located in a single setting, rather than dispersed in various locations within the center, was deemed more advantageous.

“We have it , diabetic educator , clinical pharmacist , and GP all in one place , so they all work together for assessment of patient and education , particularly high-risk patient” [Pharmacist 4].

Theme 3.4: time constraints impede collaboration and affect patient outcomes

Participants identified time constraints as a significant challenge to collaboration, with health professionals struggling to allocate sufficient time for documentation, communication, and knowledge-sharing, potentially impacting patient outcomes.

“We can’t afford the luxury of opening CERNER each time since we are already occupied with other tasks” [Pharmacist 5]. “Even when there is an issue …. we should learn from it. We are not learning. We just want to finish this issue and just move on because there is no time. There is too much work” [Laboratory technologist 1].

Theme: 3.5: lack of clarity in scope of practice leads to misunderstandings and hinders collaboration

A number of health professionals expressed concerns regarding the potential misunderstanding of their scope of practice, leading to requests to perform tasks beyond their designated role which impact the collaborative culture leading to frustration.

“Nurses are responsible for taking vital signs , following the patient’s care plan , and managing medications , but cleaning is not part of their role although some doctors mistakenly believe it to be so” [Nurse 3]. “At times , we notice that some GPs are unaware of the difference between a technician and a radiologist” [Laboratory technologist 1].

Gears domain 4: individual factors

Theme 4.1: prior exposure to ipe enhances appreciation for ipc.

The study observed that health professionals who had prior experience with IPE exhibited a greater appreciation towards collaborative work.

“We learned and practiced IPE during our education. However , in practical settings , there is still a need for a comprehensive understanding of IPE and its implementation. While there are individual efforts to apply it , full implementation has not been achieved yet” [Pharmacist 3].

Theme 4.2: health professionals’ factors

Subtheme 4.2.1: effective communication skills drive enhanced collaboration among health professionals.

Effective communication was deemed crucial by participants in healthcare settings. Nurses felt valued and integral to the team when equipped with proper communication skills, while GPs found direct communication with other health professionals to be advantageous, enhancing their practice.

“Quite a few times , I’ve reached out to the on-site ophthalmologist by phone. When there’s a concern about a patient , whether its suspected cornea issues or the need to rule out certain conditions , a simple phone call often results in them accommodating the patient. The ophthalmologist has consistently been responsive and helpful in these interactions” [GP 6].

Subtheme 4.2.2: positive interpersonal qualities among health professionals enhance collaboration

The collaboration within the team is influenced by health professionals’ interpersonal qualities which was identified as a significant factor, with approachability and friendliness being crucial in facilitating collaboration.

“The difference here is that I find everybody to be approachable and friendly [GP 6]. Very friendly environment. You can approach the nurses , the doctors—everyone is accessible” [GP 10].

Furthermore, respect and trust were highly valued facilitators of IPC and were discussed in conjunction with other facilitators.

“Mutual respect among all health professionals will facilitate smoother and more effective collaboration” [Nurse 3]. “We must respect each other. Just because I am a GP , it doesn’t mean my opinion is the only opinion or the correct one” [GP 3].

Theme 4.3: patient perceptions impact IPC

Patient perceptions were found to exert a considerable impact on the dynamics of collaboration between nurses, GPs, and other health professionals. Participants reported that patients tended to perceive nurses as occupying a subordinate position relative to GPs, and consequently, were less forthcoming in discussing healthcare concerns with them.

“ You are the nurse; you know less than the doctor” [Nurse 4]. “ Patients typically highly value recommendations from physicians. However , when they seek advice or education from nurses or pharmacists , they sometimes may not value it as much as they would if it came from a physician ” [Pharmacist 7].

Additionally, participants believe patients regard GPs as the key health professionals, and preferred to communicate exclusively with them. This perception placed an additional workload on GPs, leading to potential consequences on their capacity to collaborate effectively with other health professionals.

“We need to educate patients more about the roles each team member plays and how we all work together as a team. When a patient comes in , they often see the doctor as the leader but it’s important for them to understand the contributions of all team members” [GP 5].

Theme 4.4: impact of of perceived approachability and ego on IPC

On the other hand, encountered challenges in communicating with GPs, including when they perceived a sense of ego, or if they were less approachable. Nurses expressed reluctancy to approach pharmacists or GPs whom they felt would not respect them.

“ Being approachable is one of the most important things especially when it comes to the team. For example , some of the nurses would know a lot of information about the patient but if you’re not an approachable GP , they will not come and voluntarily divulge the information” [GP 6]. “Ego. When you are dealing with people these things are barriers and the best solution is always communication” [Nurse 6].

Similarly, GPs encountered similar challenges in communicating with other health professionals if they perceived them as unfriendly or unapproachable. However, they differed from the nurses in that they seemed to encounter these challenges within their own field of practice rather than in interactions with other health professionals.

Theme 5: enhancing IPC through equity, training, and support

The study participants put forth several proposals to enhance IPC in their workplace. A key recommendation was to ensure equity among health professionals, such that all members had full and equal access to patient files. This would enable effective IPC by keeping all team members abreast of the patient’s evolving health status and treatment plan. Participants recognized that institutional and leadership support would be necessary to achieve this equity. Additionally, due to the acknowledged limitations posed by workload and time constraints, many participants suggested that the recruitment of additional staff could facilitate IPC processes. Further, the participants proposed the need for more frequent training sessions to improve communication skills, enhance system and documentation writing, and provide IPC disease management, role clarification, and professional competencies education.

“When they send you for training you will be empowered” [Nurse 2].

Finally, health professionals emphasized the importance of a supportive system that offers constructive feedback to identify weaknesses and facilitate continuous improvement of practice. In addition, health professionals remarked on the impact of managerial support on collaboration and performance.

“When we receive support from the health center manager during our practice , we find that collaboration improves , leading to better outcomes” [Pharmacist 2].

This qualitative focus group study explored facilitators of and barriers to IPC as perceived by health professionals (including GPs, nurses, pharmacists, dentists, and allied health professionals) from various backgrounds in primary healthcare in Qatar using the “Gears” conceptual model. Overall, the majority of health professionals who participated in this study have acknowledged and appreciated the importance of IPC work within their institutions, which is consistent with other published studies [ 27 , 31 , 32 ].

Facilitators under the micro-gear domain focused on healthcare teams. Participants agreed that the diversity of health professionals within the same PHCC is a major facilitator for better collaboration. They also agreed that the presence of different communication channels (e.g. telephones, CERNER, etc.) is another facilitator. Supportive leaders in the team were acknowledged to have a positive influence on attitudes toward IPC. IPE activities were identified as positively influencing attitudes towards toward IPE and IPC. These findings are consistent with those of other studies. There was an agreement among several studies regarding the importance of open communication and various communication strategies and tools in facilitating IPC [ 33 , 34 ]. For example, Müller et al. [ 33 ], in their study where authors interviewed several clinical executive managers, found that participants agreed that multilateral communication is one of the enablers for effective IPC. Facilitators within the individual-gear, includes Individual contextual factors contributing to IPC such as previous exposure to IPC, patient related factors, and characteristics of health professionals. Previous exposure to IPC emerged as a significant facilitator for both health professionals and patients. Communication skills were identified as crucial in supporting exposure to IPC. Participants highlighted the importance of accessible communication methods, such as availability by phone or in person conversations, eliminating roadblocks to IPC. Furthermore, the approachability of health professionals, characterized by their openness to information sharing and their trust and respect for the competency, knowledge, and skills of other health professionals was a key facilitator to IPC.

Regarding the meso-gear facilitators, participants valued the importance of receiving ongoing, and timely feedback based on practice experiences to consolidate learning and minimize recurrence of errors. They advocated for utilizing data from platforms such as Datix; an Incident Reporting System (IRS), which is a valuable resource among all team members involved in patient care. Participants recommend a wider use of such data for learning, in interprofessional team meetings. This aligns with evidence from the literature which suggests that critical to the success of any IRS is the quality of the feedback given to reporters to enable learning, encourage reporting, and give reporters evidence that the information they are providing is being used appropriately [ 35 , 36 ]. Space and proximity are reported as excellent opportunity for teams to work together and share perspectives in the care for the patient [ 37 ]. As new PHCC centers are created to serve the growing needs of Qatar’s population, leaders can benefit from including members of the care teams, in the final design discussions, so that space and proximity can continue to remain optimal and facilitate interprofessional practice and team centered patient care.

The least number of factors were identified under the macro-gears. These relate to governance and regulations, which were considered as a major facilitator for better IPC in the primary healthcare setting in Qatar. The participants in this study had reflected on the existing policy and regulatory facilitators that foster collaborative practice in PHC setting in Qatar, but did not discuss barriers to policies and regulations. The study findings reaffirm the potential role and influence of government policies and regulations in facilitating IPC in primary care settings from the perspective of the health professionals. Additionally, organizational-level policies were also perceived as key facilitators. This aligns with the macro-level factors of the Gears conceptual model, which allows the conceptualization of the intricate relationships between this and the other domains of the model from the perspective of the health professionals. Previous studies have documented the influence of policy and regulation in promoting collaborative practice and IPE. One international review has summarized the global policies and legal factors influencing the behaviors of health professionals towards successful implementation of collaborative practice [ 38 ]. These factors largely influence the scope of practice of various health professions and how the different professions work collaboratively, funding mechanisms, and reimbursement systems for health services.

In Qatar, health professions and practices are regulated by the Department of Healthcare Professions under the Ministry of Public Health (MoPH) [ 39 ], which is considered a key aspect of professional practice [ 38 ]. Although there are no umbrella laws to regulate multiple health professions under a single statute, which is a major drawback to an effective and conducive implementation of collaborative practice in various settings, having a unified regulatory and legal structure has been shown to foster a culture of equity among different health professionals [ 40 ]. An important aspect of policy and professional regulation is the scope of practice, which should typically clarify roles and represent specific areas of competence for each particular health profession. Participants indicated the presence of scope of practice for various professions in the State of Qatar. Previous studies and reports have highlighted the importance of restructuring the scope of practice of health professions towards effective IPC and to remove barriers to healthcare provision. This will allow health professionals to practice within the scope of their practices and to the full extent of their professional competence without encroaching other professions’ scope of practice, which will ultimately lead to effective collaborative practice [ 41 , 42 ]. In addition, funding and reimbursement are macro-level aspects that can significantly impact IPC [ 40 , 43 ]. In the present study, there was a consensus that these regulatory factors play a key role in facilitating the IPC among the health professionals in primary care settings in Qatar.

Barriers pertaining to the healthcare teams, or the micro-gear, are the lack of understanding of other professionals’ scope of practice, and the lack of time. This is not different from what is reported in the literature, where lack of time and poor understanding of other health professionals ' roles were considered, besides other barriers, major hinderers for IPC in one review paper that collected multiple articles that studied the enablers and hinderers of IPC [ 34 ]. For the individual-gear barriers, health professionals identified that the hierarchy entrenched within the healthcare system contributed a major barrier to collaboration. Within the studied context, GPs are seen as the pinnacle health professional by patients. Therefore, patients are reluctant to provide information to health professionals other than the GP. This ultimately reduces the effectiveness of the healthcare system as the scope of practice of the remainder of the interprofessional team are constrained to meet patient needs. This might limit other health professionals’ roles, and hence they might be less able to exchange care. This idea might go with the concept of the “patient-doctor dyad” that has been reported in the literature, where authors described that one of the hinderers of IPC is the patient’s desire to be mainly seen and examined by GPs, which is often prioritized over collaborative care [ 44 , 45 , 46 ]. Pharmacists, in this study, described that patients also might ignore pharmacists’ recommendations if it was not aligned with the GPs’ recommendations. While IPC may beget IPC, participants remarked that there was difficulty bringing IPC to life in their PHCC context. Knowledge of IPC must be accompanied by a shift in organizational culture, supported by policies and performance review, led by champions, and guided by exemplars of IPC.

Two subthemes were considered under the meso-factors, which are mainly regarding the information system and the organizational culture. Our results indicate that although a health information system (HIS) is operating within the primary healthcare center (PHCC) system, however, not all members of the team use nor rely on it, to complete their duties in patient care. This fragmentation of data systems poses a threat to team unity and excludes some team members (in this context the pharmacists) from being on the same page as the rest. Efforts to merge all data subunits and enable all team members to access the HIS, can enhance work time efficiency (a micro challenge) that participants reported for pharmacists to require in order to be on the same page as the other care providers in the team and is supported by research which stresses the benefits of a health information system which enables the participation of all staff who are directly concerned with patient care in that setting [ 47 , 48 ].

In the interest of optimizing patient safety, whilst participants in this study valued the opportunity for a shared HIS to serve as a platform where errors could be recorded, our data indicates that health care team members did not feel safe enough to do so. According to Smiley and colleagues [ 49 ] the fear of being fired and subjected to judicial inquiry and prosecution make many nurses conceal errors. This aligns with our participants’ reported concerns about the prevalence of “blame culture” and how this results in individuals feeling personally and professionally vulnerable. Blame culture in health care organizations is mainly associated with the approach used by management when dealing with medical errors and accidents [ 50 , 51 ]. Efforts to embrace a culture that promotes transparency and accountability, and management approach which as described by Catino [ 52 ] relates the causal factors of a given event to the whole organization rather than the individual, are priorities for the PHCC organizational leadership to consider.

Furthermore, hierarchy in privileges, such as varied levels of access to professional development opportunities, threatens team unity, and in turn generates a sense where some professions feel less valued for working in their roles. Educators postulate that if individuals from different professions learn together, they will be able to more effectively work together in teams to achieve desired outcomes [ 53 ]. Integrating CPD in interprofessional decision support with quality improvement and patient safety initiatives will likely enhance the uptake and ability to sustain these educational initiatives [ 54 ]. For instance, the “Schwartz Center Rounds” in the US and UK provide a forum in which professional and nonprofessional staff across healthcare disciplines can discuss challenging psychosocial and emotional aspects of a patient’s care and the impact of these challenges on the care team. These rounds do not focus solely on decision-making, but attendees report significantly enhanced appreciation of colleagues’ roles and contributions, communication, and teamwork [ 55 ]. In this way, the professional learning needs can meet not only the individual profession, but also translate into opportunities for teams to problem solve together and in turn improve safer patient care.

In general, the current study results on facilitators and barriers to IPC align well with those identified by a review study by [ 34 ] that summarized the facilitators and barriers for interprofessional care in primary healthcare. Common facilitators in both studies are the lack of time and training for the health professionals, lack of understanding of others’ roles, and poor communication. It is interesting to note that fears relating to professional identity were identified as a hinderer in the review; however, it was not mentioned by any HCP in the current study. This could be due to the proper understanding of the self-role of the HCP in this study. IPC enablers identified by the review were all reported in this study (i.e. communication tools, co-location of HCP, and recognition of other professionals’ roles and contributions).

Strengths and limitations

One strength of this study is the use of the “Gears model” to understand facilitators and barriers at each level within the IPCTs. Identifying the facilitators and barriers at each level of the work environment makes it easier for decision-makers to identify the gaps and the points that need improvement specific for each level, and hence will help implement appropriate, and probably more efficient, interventions suitable for each level to improve IPC within the PHCC settings. The current study included a high diversity of health professionals and did not focus on certain professions, which aligns with what interprofessional work is all about. This study, as mentioned before, is a continuation of a previous quantitative study done on more than 1400 health professionals to assess their attitude toward IPC. Although the previous study showed that health professionals have a positive attitude toward IPC, which was evident by the survey, the current study examined these quantitative findings from a qualitative lens. This provided a clearer insight to ensure a comprehensive understanding of what shapes these perspectives.

Limitations of the study might include the lack of anonymity in focus groups, which might increase the social desirability. Second, although the study included multiple professions, most participants were GPs, pharmacists, or nurses. Moreover, some HCP were not present (e.g. pharmacy technicians, and physiotherapists), which could limit the generalizability of the current study to these professions.

The interplay between the meso, macro, micro, and individual gears showcases the importance of a multifaceted approach to interventions to amplify the successes of IPC. Policies such as data sharing and collaborative key performance indicators support the interaction between the meso and individual gears. The individual assists the macro and meso gears through communication and trust in the scope of practice of the other team members. Simultaneously, health professionals must advocate for their colleagues to patients. Patients have a direct connection to the micro and individual gears which ultimately affect the care being provided to them.

Data availability

No datasets were generated or analysed during the current study.

World Health Organization. Global strategy on human resources for health: workforce 2030. 2016.

World Health Organization. Framework for action on interprofessional education and collaborative practice. Geneva: World Health Organization; 2010.

Google Scholar  

Bodenheimer T, Chen E, Bennett HD. Confronting the growing burden of chronic disease: can the U.S. health care workforce do the job? Health affairs. (Project Hope). 2009;28(1):64–74.

Article   Google Scholar  

Freeth D. Sustaining interprofessional collaboration. J Interprof Care. 2001;15(1):37–46.

Article   CAS   PubMed   Google Scholar  

Zwarenstein M, Goldman J, Reeves S. Interprofessional collaboration: effects of practice-based interventions on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2009(3):Cd000072.

Tremblay D, Roberge D, Touati N, Maunsell E, Berbiche D. Effects of interdisciplinary teamwork on patient-reported experience of cancer care. BMC Health Serv Res. 2017;17(1):218.

Article   PubMed   PubMed Central   Google Scholar  

Mulvale G, Embrett M, Razavi SD. Gearing up’ to improve interprofessional collaboration in primary care: a systematic review and conceptual framework. BMC Fam Pract. 2016;17:83.

Gaboury I, Bujold M, Boon H, Moher D. Interprofessional collaboration within Canadian integrative healthcare clinics: key components. Soc Sci Med. 2009;69(5):707–15.

Article   PubMed   Google Scholar  

Patel PH, Welsh C, Foggs MB. Improved asthma outcomes using a coordinated care approach in a large medical group. Dis Manag. 2004;7(2):102–11.

Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev. 2001;2000(1):Cd001481.

PubMed   Google Scholar  

McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004;44(4):810–9.

Propp KM, Apker J, Zabava Ford WS, Wallace N, Serbenski M, Hofmeister N. Meeting the complex needs of the health care team: identification of nurse-team communication practices perceived to enhance patient outcomes. Qual Health Res. 2010;20(1):15–28.

Pike AW, McHugh M, Canney KC, Miller NE, Reiley P, Seibert CP. A new architecture for quality assurance: nurse-physician collaboration. J Nurs Care Qual. 1993;7(3):1–8.

Uddin S, Hossain L, Kelaher M. Effect of physician collaboration network on hospitalization cost and readmission rate. Eur J Public Health. 2012;22(5):629–33.

Busse R, Scheller-Kreinsen D, Zentner A. Tackling chronic disease in Europe: strategies, interventions and challenges. WHO Regional Office Europe; 2010.

Campbell-Scherer D. Multimorbidity: a challenge for evidence-based medicine. Evid Based Med. 15. England2010. pp. 165-6.

Wijlhuizen GJ, Perenboom RJ, Garre FG, Heerkens YF, van Meeteren N. Impact of multimorbidity on functioning: evaluating the ICF Core Set approach in an empirical study of people with rheumatic diseases. J Rehabil Med. 2012;44(8):664–8.

van Oostrom SH, Picavet HS, de Bruin SR, Stirbu I, Korevaar JC, Schellevis FG, et al. Multimorbidity of chronic diseases and health care utilization in general practice. BMC Fam Pract. 2014;15:61.

Hutchison B, Levesque J-F, Strumpf E, Coyle N. Primary health care in Canada: systems in motion. Milbank Q. 2011;89(2):256–88.

Ontario Ministry of Health and Long-, Term C. Patients first: Action Plan for health care. Ministry of Health and Long-Term Care Toronto, ON; 2015.

Shaffer J, Wexler LF. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care. Arch Intern Med. 1995;155(21):2330–5.

Chan DS, Callahan CW, Moreno C. Multidisciplinary education and management program for children with asthma. Am J health-system Pharmacy: AJHP : Official J Am Soc Health-System Pharmacists. 2001;58(15):1413–7.

Article   CAS   Google Scholar  

Gucciardi E, Espin S, Morganti A, Dorado L. Exploring interprofessional collaboration during the integration of diabetes teams into primary care. BMC Fam Pract. 2016;17:12.

Busari JO, Moll FM, Duits AJ. Understanding the impact of interprofessional collaboration on the quality of care: a case report from a small-scale resource limited health care environment. J Multidisciplinary Healthc. 2017;10:227–34.

Schepman S, Bakker D, Batenburg R. The role of health care professionals in collaboration in primary health care. Int J Integr Care. 2019;19:496.

Supper I, Catala O, Lustman M, Chemla C, Bourgueil Y, Letrilliart L. Interprofessional collaboration in primary health care: a review of facilitators and barriers perceived by involved actors. J Public Health. 2015;37(4):716–27.

CAS   Google Scholar  

Seaton J, Jones A, Johnston C, Francis K. Allied health professionals’ perceptions of interprofessional collaboration in primary health care: an integrative review. J Interprof Care. 2021;35(2):217–28.

El-Awaisi A, Awaisu A, Aboelbaha S, Abedini Z, Johnson J, Al-Abdulla SA. Perspectives of Healthcare Professionals toward Interprofessional Collaboration in primary care settings in a Middle Eastern Country. J Multidiscip Healthc. 2021;14:363–79.

PHCC. Primary Health Care Corporation Corporate Strategic Plan (2019–2023): a healthier future for our families. Primary Health Care Corporation; 2019.

Kyngäs HA, Mikkonen K, Kääriäinen M. The application of content analysis in Nursing Science Research. The application of content analysis in Nursing Science Research; 2020.

Bosch B, Mansell H. Interprofessional collaboration in health care: lessons to be learned from competitive sports. Can Pharmacists J / Revue des Pharmaciens Du Can. 2015;148(4):176–9.

Sangaleti C, Schveitzer MC, Peduzzi M, Zoboli ELCP, Soares CB. Experiences and shared meaning of teamwork and interprofessional collaboration among health care professionals in primary health care settings: a systematic review. JBI Evid Synthesis. 2017;15(11):2723–88.

Müller C, Zimmermann L, Körner M. Förderfaktoren Und Barrieren Interprofessioneller Kooperation in Rehabilitationskliniken – Eine Befragung Von Führungskräften. Rehabilitation (Stuttg). 2014;53(06):390–5.

Rawlinson C, Carron T, Cohidon C, Arditi C, Hong QN, Pluye P, et al. An overview of reviews on Interprofessional Collaboration in primary care: barriers and facilitators. Int J Integr Care. 2021;21(2):32.

Anderson JE, Kodate N, Walters R, Dodds, AJIjfqihc. Can incident reporting improve safety? Healthc Practitioners’ Views Eff Incident Report. 2013;25(2):141–50.

Waring, JJJSs. Medicine. Beyond blame: cultural barriers to medical incident reporting. 2005;60(9):1927–35.

Oandasan IF, Conn LG, Lingard L, Karim A, Jakubovicz D, Whitehead C et al. The impact of space and time on interprofessional teamwork in Canadian primary health care settings: implications for health care reform. 2009;10(2):151–62.

Girard MA. Interprofessional education and collaborative practice policies and law: an international review and reflective questions. Hum Resour Health. 2021;19(1):9.

Ministry of Public Health. Department of Healthcare Professions 2020 [ https://dhp.moph.gov.qa/en/Pages/Home.aspx

San Martín-Rodríguez L, Beaulieu M-D, D’Amour D, Ferrada-Videla, MJJoic. Determinants Success Collaboration: Rev Theoretical Empir Stud. 2005;19(sup1):132–47.

Dower C, Moore J, Langelier MJHA. It is time to restructure health professions scope-of-practice regulations to remove barriers to care. 2013;32(11):1971–6.

Safriet BJJYJoR. Closing the gap between can and may in health-care providers’ scopes of practice: a primer for policymakers. 2002;19:301.

Guindo LA, Wagner M, Baltussen R, Rindress D, van Til J, Kind P et al. From efficacy to equity: literature review of decision criteria for resource allocation and healthcare decisionmaking. 2012;10(1):1–13.

O’Reilly P, Lee SH, O’Sullivan M, Cullen W, Kennedy C, MacFarlane A. Assessing the facilitators and barriers of interdisciplinary team working in primary care using normalisation process theory: an integrative review. PLoS ONE. 2017;12(5):e0177026.

Hills M, Mullett J, Carroll S. Community-based participatory action research: transforming multidisciplinary practice in primary health care. Rev Panam Salud Publica. 2007;21(2–3):125–35.

Shaw A, de Lusignan S, Rowlands G. Do primary care professionals work as a team: a qualitative study. J Interprof Care. 2005;19(4):396–405.

Stavropoulou C, Doherty C, Tosey PJTMQ. How effective are incident-reporting systems for improving patient safety? A systematic literature review. 2015;93(4):826–66.

Herzer KR, Mirrer M, Xie Y, Steppan J, Li M, Jung C et al. Patient safety reporting systems: sustained quality improvement using a multidisciplinary team and good catch awards. 2012;38(8):339–AP1.

Smiley RA, McCarthy CJJNR. A mixed-methods study of gender differences in nurse reporting and nurse discipline. 2016;7(3):33–40.

Edie Brous RN JJJoNL. The criminalization of unintentional error: implications for TAANA. 2008;12(1):5.

Gorini A, Miglioretti M, Pravettoni, GJJoeicp. A new perspective on blame culture: an experimental study. 2012;18(3):671–5.

Catino, MJJoc. management c. A review of literature: individual blame vs. organizational function logics in accident analysis. 2008;16(1):53–62.

Association of American Medical Colleges. Interprofessional Education 2010 [ https://www.aamc.org/what-we-do/mission-areas/medical-education/interprofessional-education

Lown BA, Kryworuchko J, Bieber C, Lillie DM, Kelly C, Berger B et al. Continuing professional development for interprofessional teams supporting patients in healthcare decision making. 2011;25(6):401–8.

Lown BA, Manning CFJAM. The Schwartz Center rounds: evaluation of an interdisciplinary approach to enhancing patient-centered communication, teamwork, and provider support. 2010;85(6):1073–81.

Download references

Acknowledgements

Thanks to Dr. Jessie Johnson from the University of Calgary-Qatar for her initial support with this project. Also, we would like to thank all health professionals from primary health care who volunteered to participate in this study.

This publication was supported by Qatar University Student Grant [QUST-1-CPH-2020-25]/ [QUST-2-CPH-2019-3]. The findings achieved herein are solely the responsibility of the author[s].

Author information

Authors and affiliations.

Department of Clinical Pharmacy and Practice, College of Pharmacy, QU Health, Qatar University, Doha, Qatar

Alla El-Awaisi, Abier Mohamed Elboshra, Kawthar Hasan Jasim, Alzahraa Fathi AboAlward & Ahmed Awaisu

Hamad Medical Cooperation, Doha, Qatar

Ola Hasan Yakti

Primary Health Care Corporation, Doha, Qatar

Raghad Walid Shalfawi & Noora Al Mutawa

College of Pharmacy, Dalhousie University, Halifax, Canada

Daniel Rainkie

Department of Clinical Academic Education, College of Medicine, QU Health, Qatar University, Doha, Qatar

Noora Al Mutawa

Division of Medical Education, Weill Cornell Medicine – Qatar, Doha, Qatar

Stella Major

You can also search for this author in PubMed   Google Scholar

Contributions

AE contributed to the conception of this research idea, study design, data collection, data analysis, and including supporting all stages of this paper. AME, KJ, AAZ, RS accompanied AE in the focus groups. AME, KJ, AAZ, RS, AA, DR, NA, SM supported with the study design, study conceptualization, analysis, and interpretation of findings. OY supported with the data validation, analysis, and interpretation of findings. All authors contributed to drafting the manuscript and reviewed and approved the final version of the manuscript.

Corresponding author

Correspondence to Alla El-Awaisi .

Ethics declarations

Ethics approval and consent to participate.

Ethics approval was obtained from the PHCC Research Committee (PHCC/RC/18/12/001) and the Qatar University Institutional Review Board (QU-IRB 1084-EA/19). All participants received information leaflet about the study and that their participation in the qualitative study would be voluntarily and will be treated confidentially. All participants signed and dated the written informed consent form. The study was carried out in accordance to the relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ .

Reprints and permissions

About this article

Cite this article.

El-Awaisi, A., Yakti, O.H., Elboshra, A.M. et al. Facilitators and barriers to interprofessional collaboration among health professionals in primary healthcare centers in Qatar: a qualitative exploration using the “Gears” model. BMC Prim. Care 25 , 316 (2024). https://doi.org/10.1186/s12875-024-02537-8

Download citation

Received : 08 December 2023

Accepted : 22 July 2024

Published : 27 August 2024

DOI : https://doi.org/10.1186/s12875-024-02537-8

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

• Interprofesisonal collaboration
• Interprofessional education
• Collaborative practice
• Primary care
• “Gears” Conceptual Model
• Perpsectives
• Qualitative
• Middle East

BMC Primary Care

ISSN: 2731-4553

• General enquiries: [email protected]

Explore QF your way

We know this can be a complex organization to navigate sometimes. that`s why we've put together tailored journeys based on your needs., ask botaina.

Looking for quick answers about QF and our programs? Let’s Chat

• Media center
• Education City
• Accessibility accessibility_icon

Qatar Precision Health Institute

Qatar Precision Health Institute (QPHI) is a national center for research and implementation under Qatar Foundation.

Its primary focus is to enhance precision healthcare quality and value through comprehensive study of genomics and multi-omics.

QPHI was conceptualized to leverage more than 10 years of valuable data collection, research, and ecosystem development accomplished by Qatar Biobank and Qatar Genome. The goal is to lead in preventing and curing health issues through personalized approaches, and consequently empower and enable precision health practices leading to healthy and vibrant communities.

• Phone +974 4454 1177
• Email [email protected]
• Address Qatar Biobank, Doha, Qatar See on map

Melding AI and RNA: Penn’s $18 Million AIRFoundry to Revolutionize RNA Research

By Ian Scheffler

In a typical foundry, raw materials like steel and copper are melted down and poured into molds to assume new shapes and functions. The U.S. National Science Foundation Artificial Intelligence-driven RNA Foundry (NSF AIRFoundry), led by the University of Pennsylvania and the University of Puerto Rico and supported by an $18-million, six-year grant, will serve much the same purpose, only instead of smithing metal, the “BioFoundry” will create molecules and nanoparticles. 

NSF AIRFoundry is one of five newly created BioFoundries, each of which will have a different focus. Bringing together researchers from Penn Engineering , Penn Medicine’s Institute for RNA Innovation , the University of Puerto Rico–Mayagüez (UPR-M), Drexel University , the Children’s Hospital of Philadelphia (CHOP) and InfiniFluidics , the facility, which will be physically located in West Philadelphia and at UPR-M, will focus on ribonucleic acid (RNA), the tiny molecule essential to genetic expression and protein synthesis that played a key role in the COVID-19 vaccines and saved tens of millions of lives. 

The facility will use AI to design, optimize and synthesize RNA and delivery vehicles by augmenting human expertise, enabling rapid iterative experimentation, and providing predictive models and automated workflows to accelerate discovery and innovation.

“With NSF AIRFoundry, we are creating a hub for innovation in RNA technology that will empower scientists to tackle some of the world’s biggest challenges, from health care to environmental sustainability,” says Daeyeon Lee , Russell Pearce and Elizabeth Crimian Heuer Professor in Chemical and Biomolecular Engineering in Penn Engineering and NSF AIRFoundry’s director. 

“Our goal is to make cutting-edge RNA research accessible to a broad scientific community beyond the health care sector, accelerating basic research and discoveries that can lead to new treatments, improved crops and more resilient ecosystems,” adds Nobel laureate Drew Weissman , Roberts Family Professor in Vaccine Research in Penn Medicine, Director of the Penn Institute for RNA Innovation and NSF AIRFoundry’s senior associate director.

The facility will catalyze new innovations in the field by leveraging artificial intelligence (AI). AI has already shown great promise in drug discovery, poring over vast amounts of data to find hidden patterns. “By integrating artificial intelligence and advanced manufacturing techniques, the NSF AIRFoundry will revolutionize how we design and produce RNA-based solutions,” says David Issadore , Professor in Bioengineering and in Electrical and Systems Engineering at  Penn Engineering and the facility’s associate director of research coordination.

InfiniFluidics, a Philadelphia-based startup co-founded by Lee and Issadore, along with collaborators from UPR-M, Drexel and CHOP will work closely to improve the design and manufacture of lipid nanoparticles (LNPs), the tiny, fatty vessels that can deliver RNA inside cells. Just as foundries provide other manufacturers with metal, NSF AIRFoundry will supply any lab, biotechnology company or pharmaceutical firm with high-quality, customizable ingredients for RNA and LNP experiments. 

In addition, the facility will foster collaboration among RNA scientists with an AI-powered platform. “The knowledge-sharing platform we are developing will allow researchers to collaborate and share insights in ways that were never before possible,” says Zachary Ives , Adani President’s Distinguished Professor in Computer and Information Science at Penn Engineering and NSF AIRFoundry’s associate director of knowledge sharing. 

The facility will also democratize research and train the next generation of RNA scientists by offering educational programs, workshops and research opportunities. “We are not only advancing scientific knowledge but also broadening participation, ensuring that students and scientists from all backgrounds have the opportunity to contribute to and benefit from this emerging field,” says Claribel Acevedo-Vélez , Associate Professor in Chemical Engineering at UPR-M and associate director of education and diversity at NSF AIRFoundry.

Ultimately, says Lee, “NSF AIRFoundry will bring about the RNA revolution by leveraging the power of the molecules that saved millions of lives and the AI that is changing the world.”

To learn more about NSF AIRFoundry, please contact Holly Wojcik at Penn Engineering ( [email protected] ), Alex Gardner at Penn Medicine ( [email protected] ) and NSF Public Affairs ( [email protected] ). 

• Media Center
• Virtual Tour

• Core Facilities

The WCM-Q genomics core laboratory is committed to provide the research community across Qatar access to cutting edge genomics technologies. These technologies are offered as service-for-fee or collaborations depending on the research project’s needs. The WCM-Q genomics core assists researchers in selecting the genomic technology that best fits their project.

The core strives to stay up to date with the fast-paced development of the genomics field by continually implementing new technologies, improving protocols, and developing processes to consistently generate high-quality data. 

Genomics Core Facility The genomics core laboratory is equipped with the latest genomic analysis equipment including Next Generation DNA Sequencers, Microarray Platforms, Real-Time PCR instruments, Droplet Digital PCR instrument, Single-cell Platforms, Long-Read Sequencers, etc.

• Skip to content
• Skip to footer
• Our Stories

• Drug Ordering for Pharmacies
• Specialty Drugs for Physician Practices
• Plasma & Biologics for Non-Physicians
• Brand Name Drugs
• Generic Drugs
• OTC Pharmacy Products
• Controlled Substance Ordering (CSOS)
• Drug Packaging Solutions
• Post Acute Care Supplies
• Surgery Center Supplies & Equipment
• Physician Supplies
• Non-Acute Supplies
• Lab Supplies & Equipment
• Home Medical Equipment
• Emergency Medical Products
• Flu Vaccines
• SupplyManager Medical Supply Ordering
• Pharmacy Ownership Consulting
• Health Mart Franchise Program
• Consulting & Software Solutions
• Prescribed Perspectives
• Health Mart Atlas
• McKesson Specialty Network
• Pharmacy Management Software
• Pharmacy Operations
• Pharmacy Automation Solutions
• Drug Purchasing Management
• Pharmacy Group Purchasing
• Pharmacy Claims Reimbursement
• Audit Risk Mitigation
• Patient Adherence & Wellness
• Alternate Site Pharmacy Solutions
• Specialties We Support
• Drug Purchasing and Management
• Advisors and Tools
• Technology Solutions
• Oncology Clinical Management Technology
• Full-Service Practice Management
• Distribution Services
• Third Party Logistics
• Clinical Trials Services
• Specialty Pharmacy
• Oncology Real-World Evidence & Provider Engagement
• Access & Adherence
• Program Pharmacy
• LoyaltyScript Co-Pay Program
• eVoucherRx Co-Pay Savings

About McKesson

• Press Releases

McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute’s Core Ventures

August 26, 2024

Acquisition enhances McKesson’s integrated oncology platform; Florida Cancer Specialists & Research Institute to join The US Oncology Network

IRVING, Texas, August 26, 2024 — McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures). Core Ventures, a business and administrative services organization, was established by Florida Cancer Specialists & Research Institute, LLC (FCS), a leading physician-owned community oncology practice. FCS physicians will continue to retain a minority interest in Core Ventures.

McKesson will purchase its controlling interest for approximately $2.49 billion in cash, which will represent approximately 70% ownership. Following completion of the transaction, Core Ventures will be part of the Oncology platform, and financial results will be reported within McKesson’s US Pharmaceutical segment. The transaction is subject to customary closing conditions, including necessary regulatory clearances. Following the close of the transaction, FCS , a practice with more than 250 physicians and 280 advanced practice providers, across nearly 100 locations in Florida, will remain independently owned and FCS will join McKesson’s The US Oncology Network (The Network), a leading oncology organization, dedicated to advancing local and affordable cancer care and better patient outcomes.

“This milestone marks an important step forward in our efforts to advance community-based oncology care,” said Brian Tyler, chief executive officer, McKesson. “By growing our Oncology platform, we will bring advanced treatments and improved care experiences to patients, while also reducing the overall cost of care. FCS and Core Ventures’ expertise and patient-first approach align with our commitment to accelerating clinical development, improving patient outcomes, and expanding access to quality cancer care in the community. We are also pleased to welcome Florida Cancer Specialists & Research Institute to The US Oncology Network, reinforcing our dedication to empowering community-based providers to independently thrive in today’s rapidly evolving healthcare landscape.”

FCS has provided exceptional care to cancer patients for over 40 years. During that time, services have grown to include clinical trials, diagnostic imaging, medical oncology and chemotherapy infusion, integrative therapy, molecular and pathology lab services, radiation oncology, next-generation sequencing, medically integrated dispensing, and data services. FCS currently conducts clinical trials through Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials. By joining The Network, FCS will have access to McKesson’s differentiated Oncology platform , including best-in-class oncology care products and services.

“Above all else, our patients are the true beneficiaries of this transaction, as we seek to drive meaningful outcomes and deliver sustained value with every interaction. Through the power of our combined operational expertise, we can bolster community oncology's role in increasing access to high-quality, affordable care,” said Lucio N. Gordan, MD , president and managing physician, FCS .

“This is a historic moment for FCS and reflects the evolution of our practice and the forward-thinking of physician leadership, our board, and the entire organization at large,” said Nathan H. Walcker , chief executive officer of FCS . “The US Oncology Network and FCS share a mission and we both aim to strengthen patient-centered cancer care in the community to improve outcomes. We are thrilled to partner with McKesson and join The Network, which furthers the joint commitment to bringing the best medicine and innovation for patients into communities across Florida.”

Cautionary Statements

Except for historical information, statements in this press release regarding McKesson’s proposed acquisition and related arrangements constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that involve risks and uncertainties that could cause actual results to differ materially from those in those statements. It is not possible to identify all such risks and uncertainties. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the company undertakes no obligation to publicly update forward-looking statements. We encourage investors to read the important risk factors described in the company’s most recent Form 10-K filed with the Securities and Exchange Commission. These risk factors include, but are not limited to: we may be unable to obtain necessary regulatory approvals; we may not achieve expected outcomes from the transaction; we might be adversely impacted by delays or other difficulties, including related to the transactions described in this press release; we from time to time record significant charges from impairment to goodwill, intangibles and other assets or investments; we might be adversely impacted by events outside of our control, such as widespread public health issues, natural disasters, political events, economic events and other catastrophic events.  

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories .

About McKesson Oncology and Specialty Solutions

It’s an unprecedented time for patients living with cancer as life sciences companies race to create new, cutting-edge therapies. With cancer care becoming more targeted, providers, life sciences companies, and payers face a multitude of challenges and complexity in the development of new treatments and making them accessible to patients in need. At McKesson , our unmatched portfolio of oncology businesses and partners provide research, insights, technologies, and services that are helping to address these hurdles and improve cancer and specialty care.

• McKesson is fueling discovery by helping patients participate in cutting-edge clinical trials closer to home through its joint venture with  Sarah Cannon Research Institute .
• The US Oncology Network and McKesson Provider Solutions are advancing specialty care and high-quality cancer care in the communities where patients live by supporting the practices of thousands of independent, community-based providers.
• Ontada ® , a McKesson business dedicated to oncology, generates real-world data (RWD) and real-world evidence (RWE), and provides clinical education and provider technology to inform and improve cancer care.
• As one of the largest distributors of oncology and specialty medicines, we are ensuring medicines make their way to those who are counting on them.
• And through CoverMyMeds , Biologics by McKesson , and GPO services , our work continues to help patients access, afford, and adhere to their medicines.

Rachel Rodriguez Investors 469-260-0556 [email protected]

Claire Crye Media 281-825-9927 [email protected]